ITEOS THERAPEUTICS INC's ticker is ITOS and the CUSIP is 46565G104. A total of 84 filers reported holding ITEOS THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,380 | -17.3% | 400,000 | 0.0% | 0.19% | +14.6% |
| Q2 2023 | $5,296 | -2.7% | 400,000 | 0.0% | 0.16% | -49.2% |
| Q1 2023 | $5,444 | -30.3% | 400,000 | 0.0% | 0.32% | -25.9% |
| Q4 2022 | $7,812 | -99.9% | 400,000 | 0.0% | 0.44% | +34.2% |
| Q3 2022 | $7,620,000 | -7.5% | 400,000 | 0.0% | 0.32% | -26.1% |
| Q2 2022 | $8,240,000 | -36.0% | 400,000 | 0.0% | 0.44% | -18.4% |
| Q1 2022 | $12,872,000 | -49.2% | 400,000 | -26.5% | 0.54% | -21.5% |
| Q4 2021 | $25,331,000 | -5.6% | 544,047 | -45.3% | 0.69% | +14.3% |
| Q3 2021 | $26,839,000 | +5.3% | 994,047 | 0.0% | 0.60% | +16.2% |
| Q2 2021 | $25,497,000 | -31.8% | 994,047 | -9.1% | 0.52% | -21.8% |
| Q1 2021 | $37,395,000 | +1.1% | 1,094,047 | 0.0% | 0.66% | -16.8% |
| Q4 2020 | $37,001,000 | +37.1% | 1,094,047 | 0.0% | 0.79% | +21.2% |
| Q3 2020 | $26,990,000 | – | 1,094,047 | – | 0.66% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 2,738,785 | $52,174,000 | 19.87% |
| MPM BioImpact LLC | 1,745,943 | $33,260,000 | 7.88% |
| Boxer Capital, LLC | 2,154,058 | $41,035,000 | 2.31% |
| TANG CAPITAL MANAGEMENT LLC | 937,500 | $17,859,000 | 2.19% |
| RA Capital Management | 4,417,259 | $84,149,000 | 1.80% |
| BVF INC/IL | 1,810,835 | $34,496,000 | 1.42% |
| Zebra Capital Management LLC | 12,271 | $234,000 | 0.89% |
| Integral Health Asset Management, LLC | 195,000 | $3,715,000 | 0.72% |
| Prairiewood Capital, LLC | 32,269 | $615,000 | 0.51% |
| DAFNA Capital Management LLC | 97,560 | $1,859,000 | 0.50% |